Alexza Pharmaceuticals Inc. (ALXA) Stock Quote

Detailed Quote for Alexza Pharmaceuticals Inc. (ALXA)

close 52 Week Information

52 Week High

June 30, 2011

Close: 1.91

52 Week Low

December 8, 2011

Close: 0.51

Today

Last Price
0.725

Change $
0.04

Change %
5.84%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
0.68

High
0.7399

Low
0.68

Prev Close
0.685

Last Trade
2/10/12

Volume
146.26 k

52 Wk Hi
1.91

52 Wk Low
0.51

Market Cap
52.3 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
72,136,338

EPS (TTM)
0.01

PE Ratio
72.50

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Alexza Pharmaceuticals Inc. (ALXA)

Sector News | Topic News

News for ALXA

Mon, Jan 23, 2012

8:30 AM

Alexza Announces Extension of the ADASUVE(tm) PDUFA Goal Date by Three Months - PR Newswire

Wed, Jan 04, 2012

7:00 AM

Annual CNS Overview Issue Released by NeuroPerspective - Marketwire

Fri, Dec 16, 2011

8:00 PM

Alexza Retains Lazard to Explore Strategic Options - PR Newswire

Tue, Dec 13, 2011

5:00 AM

FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE(tm) - PR Newswire

Thu, Dec 01, 2011

8:16 AM

Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day - Marketwire

Tue, Nov 08, 2011

9:00 AM

Alexza Presents Staccato® Loxapine Responder Analyses in Agitated Adult Patients with Schizophrenia or Bipolar Disease at the 2011 USPMHC Annual Conference - PR Newswire

Mon, Nov 07, 2011

4:05 PM

Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update - PR Newswire

Wed, Nov 02, 2011

9:00 AM

Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire

Thu, Oct 27, 2011

6:00 PM

Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011 - PR Newswire

9:00 AM

Alexza Pharmaceuticals Announces Submission of European Marketing Authorization Application for Adasuve® (Staccato® Loxapine) - PR Newswire

Mon, Oct 24, 2011

9:00 AM

Alexza Announces the Adasuve(tm) (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011 - PR Newswire

Tue, Oct 11, 2011

9:15 AM

Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference - PR Newswire

Thu, Oct 06, 2011

6:00 AM

Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve(tm) (Staccato® Loxapine) in Europe and Latin America - PR Newswire

Thu, Sep 15, 2011

9:00 AM

Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference - PR Newswire

Wed, Aug 31, 2011

9:00 AM

Alexza Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011 - PR Newswire

Fri, Aug 19, 2011

9:00 AM

Alexza Announces Adasuve(tm) (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012 - PR Newswire

Mon, Oct 11, 2010

6:31 AM

Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA - Canada Newswire

Fri, Oct 01, 2010

9:51 AM

Did Alexza Pharmaceutical run out of steam? - Accesswire

More News for ALXA >>

Tags for Alexza Pharmaceuticals Inc.

Research stocks or mutual funds related to Alexza Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ALXA. The keywords below have been associated to ALXA by either user submission or electronic means.

biotechnology company biotech research pharmaceuticals research pharmaceuticals international research pharmaceutical branding australian pharmaceuticals pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics jobs in pharmaceutical mgi pharma europe pharmaceuticals pharmaceutical research and development pharmaceutical manufacturing company dupont pharmaceuticals pharmaceuticals germany pharma manufacturing novartis pharmaceuticals pharmaceuticals supply chain pharmaceutical class elan pharmaceuticals pharmaceutical cro pharma companies ivax pharmaceuticals active pharmaceutical ingredients pharmaceutical sales abo pharmaceuticals pharma pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical reports biotech Drugs pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation pfizer pharmaceuticals generic pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing merck pharmaceuticals pharmaceutical business development pharmaceuticals australia Healthcare